Open AccessP388: PREFERENTIAL SYNERGISTIC EFFECT OF INDISULAM IN COMBINATION WITH VENETOCLAX AND AZACYTIDINE IN AML CELLS WITH SF3B1 MUTATIONS.
Author(s) -
Bernardo P.,
Pereira M.,
Galvão B.,
Desterro J.,
Nunes A.,
Frade M. D. J.,
Lobato J.,
Silva M. G.,
Lemos M.,
Silva M.,
Ribeiro P.,
Matos S.,
Custódio N.,
CarmoFonseca M.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000844440.63033.80
Subject(s) - azacitidine , venetoclax , cancer research , myeloid leukemia , synthetic lethality , rna splicing , myeloid , medicine , cancer cell , biology , leukemia , mutant , gene , cancer , immunology , genetics , gene expression , dna methylation , rna , chronic lymphocytic leukemia